COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,001 Articles (22,627 medRxiv, 8,374 bioRxiv)

Most recent first Previous |  Page 877: Articles 8761-8770  | Next

Vaccination and Variants: retrospective model for the evolution of Covid-19 in Italy
Fierro, A., Romano, S., Liccardo, A.
10.1101/2022.02.27.22271593 — Posted: 2022-02-28
Study on the usefulness of Direct Saliva sample Collection (DiSC) by polyester swab
Aoki, K., Nagashima, M., Kashiwagi, K., Chiba, T., Sadamasu, K., Ishii, Y., Tateda, K.
10.1101/2022.02.25.22271529 — Posted: 2022-02-28
Assessment of indoor biological air quality at a mass gathering event in an unimproved exhibition facility during the COVID-19 pandemic using a novel air sampling technology.
Gordon, J., Abdullah, O., Reboulet, R., Hanson, k., Sadowski, C., Rennels, H., Kuemmerle, S., Tuttle, R., Solocinski, K., Knight, B., Wilkinson, J., Macgregor-Skinner, G.
10.1101/2022.02.19.22271227 — Posted: 2022-02-28
Discriminatory ability of gas chromatography-ion mobility spectrometry to identify patients hospitalised with COVID-19 and predict prognosis
Nazareth, J., Pan, D., Kim, J. W., Leach, J., Brosnan, J. G., Ahmed, A., Brodrick, E., Wicaksono, A., Daulton, E., Williams, C., Haldar, P., Covington, J., Pareek, M., Sahota, A.
10.1101/2022.02.28.22271571 — Posted: 2022-02-28
OLFACTORY TRAINING EFFICIENCY IN POST-COVID-19 PERSISTENT OLFACTORY DISORDERS
Vandersteen, C., Payne, M., Dumas, L.-E., Cancian, E., Plonka, A., D Andrea, G., Chirio, D., Demonchy, E., Risso, K., Askenazy-Gittard, F., Savoldelli, C., Guevara, N., Robert, P., Castillo, L., Manera, V., Gros, A.
10.1101/2022.02.27.22271572 — Posted: 2022-02-28
Post-acute symptoms, new onset diagnoses and health problems 6 to 12 months after SARS-CoV-2 infection: a nationwide questionnaire study in the adult Danish population
Sorensen, A. I. V., Spiliopoulos, L., Bager, P. M., Nielsen, N. M., Hansen, J. V., Koch, A., Meder, I. K., Ethelberg, S., Hviid, A.
10.1101/2022.02.27.22271328 — Posted: 2022-02-28 Discussion: Onsite
Genomic surveillance of SARS-CoV-2 in a university community: insights into tracking variants, transmission, and spread of Gamma (P.1) variant
Ciubotariu, I. I., Dorman, J., Perry, N. M., Gorenstein, L., Kattoor, J. J., Fola, A. A., Zine, A., Hendrix, G. K., Wilkes, R. P., Kitchen, A., Carpi, G.
10.1101/2022.02.25.22271521 — Posted: 2022-02-28
Comparison of Rapid Antigen Tests' Performance between Delta (B.1.61.7; AY.X) and Omicron (B.1.1.529; BA1) Variants of SARS-CoV-2: Secondary Analysis from a Serial Home Self-Testing Study
Soni, A., Herbert, C., Filippaios, A., Broach, J., Colubri, A., Fahey, N., Woods, K., Nanavati, J., Wright, C., Orwig, T., Gilliam, K., Kheterpal, V., Suvarna, T., Nowak, C., Schrader, S., Lin, H., O'Connor, L., Pretz, C., Ayturk, D., Orvek, E., Flahive, J., Lazar, P., Shi, Q., Achenbach, C. J., Murphy, R. L., Robinson, M. L., Gibson, L., Stamegna, P., Hafer, N., Luzuriaga, K., Barton, B., Manabe, Y. C., McManus, D., RADx Clinical Studies Core Team, , Test Us At Home Investigators
10.1101/2022.02.27.22271090 — Posted: 2022-02-28 Discussion: Onsite
Design, Synthesis and Evaluation of Inhibitors of the SARS-CoV-2 nsp3 Macrodomain
Sherrill, L. M., Joya, E. E., Walker, A., Roy, A., Alhammad, Y. M., Atobatele, M., Wazir, S., Abbas, G., Keane, P., Zhuo, J., Leung, A., Johnson, D. K., Lehtio, L., Fehr, A., Ferraris, D. V.
10.1101/2022.02.27.482176 — Posted: 2022-02-28
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2
Ohashi, H., Hishiki, T., Akazawa, D., Kim, K. S., Woo, J., Shionoya, K., Tsuchimoto, K., Iwanami, S., Moriyama, S., Kinoshita, H., Yamada, S., Kuroda, Y., Yamamoto, T., Kishida, N., Watanabe, S., Hasegawa, H., Ebihara, H., Suzuki, T., Maeda, K., Fukushi, S., Takahashi, Y., Iwami, S., Watashi, K.
10.1101/2022.02.27.482147 — Posted: 2022-02-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).